Hilary Beck

Hilary Beck is an accomplished chemistry professional with extensive experience in medicinal chemistry, currently serving as Vice President and Head of Chemistry at Eikon Therapeutics since April 2020, following a role as Senior Director. Previously, Hilary held the position of Director of Medicinal Chemistry at IDEAYA Biosciences from April 2016 to April 2020, and worked as a Principal Investigator at both FLX Bio, Inc. and Flexus Biosciences. Early career experience includes a Senior Scientist role at Amgen and a Postdoctoral Fellowship at the University of North Carolina at Chapel Hill. Hilary's educational background includes a Ph.D. in organic synthesis from The University of Texas at Austin and a BA in Chemistry from Boston University. Achievements encompass leading projects targeting metabolic disorders and inflammatory diseases, as well as innovating synthetic methodologies and developing key pharmaceutical compounds.